Research

Research being conducted in the clinic:

Pharmaceutical Industry sponsored trials

Studies in the planning stages:

1. A epidemiologic assessment of Parkinson’s Disease in Manitoba.
   
   
2. A survey of fatigue in Parkinson Disease.

Ongoing (recruitment open):

1. Addiction in Parkinson's – a survey: This cross Canada survey is being sponsored by Boerhinger Ingelheim. This study is to begin in the fall of 2006.

Ongoing (recruitment closed): 

1. ADAGIO: We are currently recruiting for a trial of Rasagiline vs Placebo in newly diagnosed Parkinson patients. The goal of this muticenter 12 month trial is to determine if Rasagiline is able to slow the progression of Parkinson’s disease (in addition to it’s already proven ability to improve symptoms. This trial is sponsored by Teva Neuroscience.
   
   
2. Myobloc: Open label Myobloc trial for cervical dystonia. This trial is sponsored by Elan Pharmaceuticals.
   
   
3. Istradefyline: Open label trial of Istradefyline for motor response fluctuations in Parkinson Disease. This trial is being sponsored by Kyowa Phamaceuticals. Recruitment is now closed.

Recently completed studies:
               

1. ACT 5288: Phase II randomized, multicentre, double blind, placebo controlled study of SR57667B on Dopamine Neurostriatal function assessed by PET imaging in early PD. This study is being sponsored by Sanofi~Synthelabo. Recruitment is now closed.
   
   
2. Istradefyline: Double blind trial of Istradefyline for motor response fluctuations in Parkinson Disease. This trial is sponsored by Kyowa Phamaceuticals.

Back to the MDC Home Page